Biotechnology
Immune-cell booster for cancer patients
Research
ETH Zurich
Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these.
Scientists unlock nature's secret to super-selective binding
Research
EPFL
EPFL researchers have discovered that it is not just molecular density, but also pattern and structural rigidity, that control super-selective binding interactions between nanomaterials and protein surfaces. The breakthrough could help optimize existing approaches to virus prevention and cancer detection.
The protein behind immunotherapy resistance
Research
EPFL
Scientists at EPFL, Ludwig Institute of Cancer Research, and CHUV have identified a key protein that helps tumors evade attacks by the immune system, contributing to poor responses to immunotherapy in the clinic.
Sustainable scents from the mountain of the gods
Research
ETH Zurich
ETH Zurich chemist Freideriki Michailidou is developing novel processes for the sustainable production of fragrance ingredients. As a first step, she studied the scents of rare aromatic plants that grow only on Mount Olympus in Greece.
Fighting tumours with magnetic bacteria
Research
ETH Zurich
Researchers at ETH Zurich are planning to use magnetic bacteria to fight cancerous tumours. They have now found a way for these microorganisms to effectively cross blood vessel walls and subsequently colonise a tumour.
Mapping human brain development
Research
ETH Zurich
Researchers at ETH Zurich are growing human brain-like tissue from stem cells and are then mapping the cell types that occur in different brain regions and the genes that regulate their development.
Page 4 of 9